In order to investigate whether EEBR inhibits NSCLC progression in vivo via the NF‐κB‐NLRP3‐GSDMD pathway by promoting pyroptosis, we evaluated the levels of IL‐1β and IL‐18 in tumour tissues. Here, NFKB1 is linked to non-small cell lung carcinoma.